Biohaven annual operating income
2020
2021
2022
2023
2024
2025
Biohaven Operating Income Growth & History (BHVN)
Biohaven's operating income was −$745.4M for fiscal 2025.
View full Biohaven company overviewBiohaven annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$745.4M | $139.7M | — |
| 2024 | 2024-12-31 | −$885.1M | −$449.1M | — |
| 2023 | 2023-12-31 | −$436.1M | $131.9M | — |
| 2022 | 2022-12-31 | −$567.9M | −$349.0M | — |
| 2021 | 2021-12-31 | −$218.9M | −$104.4M | — |
| 2020 | 2020-12-31 | −$114.5M | — | — |
Biohaven quarterly operating income
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$124.9M | $86.8M | — |
| Q1 2026 | 2026-03-31 | −$130.4M | $91.1M | — |
| Q4 2025 | 2025-12-31 | −$142.7M | $47.2M | — |
| Q3 2025 | 2025-09-30 | −$169.4M | $8.8M | — |
| Q2 2025 | 2025-06-30 | −$211.7M | $122.1M | — |
| Q1 2025 | 2025-03-31 | −$221.6M | −$38.3M | — |
| Q4 2024 | 2024-12-31 | −$189.9M | −$36.2M | — |
| Q3 2024 | 2024-09-30 | −$178.2M | −$67.6M | — |
| Q2 2024 | 2024-06-30 | −$333.8M | −$239.8M | — |
| Q1 2024 | 2024-03-31 | −$183.2M | −$105.5M | — |
| Q4 2023 | 2023-12-31 | −$153.7M | — | — |
| Q3 2023 | 2023-09-30 | −$110.5M | −$42.9M | — |
| Q2 2023 | 2023-06-30 | −$94.0M | $103.1M | — |
| Q1 2023 | 2023-03-31 | −$77.8M | $12.0M | — |
| Q3 2022 · Sep 30 | 2022-09-30 | −$67.6M | −$12.1M | — |
| Q2 2022 | 2022-06-30 | −$197.1M | — | — |
| Q1 2022 | 2022-03-31 | −$89.8M | — | — |
| Q3 2021 | 2021-09-30 | −$55.5M | — | — |
Biohaven operating income trends
Over the last five fiscal years, Biohaven's operating income decreased from −$114.5M to −$745.4M, a change of −$630.9M. The latest reported quarter, Q2 2026, shows −$124.9M.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biohaven source filings ↗Community posts
FDA accepts Biohaven's resubmitted application for spinocerebellar ataxia drug
Biohaven ($BHVN) said the FDA accepted its resubmitted application for Vyglxia, the proposed brand for troriluzole, to treat spinocerebellar ataxia. The submission includes additional supportive analyses and was deemed a complete response t ...
